Immediate Impact
11 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
2024 Standout
Works of Denice Hickman being referenced
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
2023
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Denice Hickman | 153 | 111 | 32 | 64 | 9 | 206 | |
| Lionel Adès | 156 | 107 | 18 | 33 | 11 | 191 | |
| W.-K. Hofmann | 116 | 156 | 13 | 60 | 9 | 262 | |
| Ramy Rahmé | 195 | 132 | 22 | 38 | 11 | 260 | |
| Marilyn Sánchez-Bonilla | 96 | 128 | 13 | 41 | 9 | 265 | |
| Veronica Guerra | 114 | 113 | 7 | 53 | 15 | 200 | |
| Mario Nicola | 79 | 175 | 10 | 38 | 9 | 236 | |
| Hans‐Günter Derigs | 104 | 61 | 31 | 37 | 8 | 160 | |
| Sue Naim | 129 | 230 | 17 | 42 | 8 | 291 | |
| Michael Leisch | 73 | 111 | 22 | 72 | 13 | 261 | |
| Sophie Dobbelstein | 162 | 101 | 40 | 65 | 7 | 255 |
All Works
Loading papers...